Multicenter, double-blind, placebo-controlled study of the use of filgrastim in patients hospitalized with pneumonia and severe sepsis* — Richard K. Root (2003) | RDL Network
Multicenter, double-blind, placebo-controlled study of the use of filgrastim in patients hospitalized with pneumonia and severe sepsis*
Article 2003 en
Authors
RR
Richard K. Root
RL
Robert F. Lodato
WP
Ward Patrick
Abstract
1 min read
The addition of filgrastim to the antibiotic and supportive care treatment of patients with pneumonia complicated by severe sepsis appeared to be safe, but not efficacious in reducing mortality rates or complications from this infection.
Todd W. Rice, Arthur P. Wheeler, Gordon R. Bernard, Jean Louis Vincent, Derek C. Angus, Naoki Aikawa, Ignace Demeyer, Stephen M. Sainati, Nicholas Amlot, Charlie Cao, Masayuki Ii, Hideyasu Matsuda, Kouji Mouri, Jon Cohen
Yupin Suputtamongkol, Sunanta Intaranongpai, Michael D. Smith, Brian Angus, Wipada Chaowagul, Chairat Permpikul, J. A. Simpson, Amorn Leelarasamee, Lloyd Curtis, Sir Nicholas White
Jean Louis Vincent, Pierre-Fran ois Laterre, Jonathan Cohen, H. Burchardi, Hajo A. Bruining, Francisco Álvarez-Lerma, Xavier Wittebole, Daniel De Backer, Stephen J. Brett, Dolores Marzo, Haruji Nakamura, Stephanie John
Konrad Reinhart, T. Menges, Bengt Gårdlund, Jan H. Zwaveling, Mark Smithes, Jean Louis Vincent, José M. Tellado, Antonio Salgado-Remigio, Reuven Zimlichman, Stuart Withington, Klaus Tschaikowsky, Rainer Brase, Pierre Damas, H. Küpper, J. Kempeni, Juergen Eiselstein, Martin Kaul
Discussion(0)
No comments yet. Be the first to comment.